KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other financing activities: 2009-2024

Historic Other financing activities for Exact Sciences (EXAS) over the last 15 years, with Dec 2024 value amounting to -$17.8 million.

  • Exact Sciences' Other financing activities rose 26.17% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.4 million, marking a year-over-year increase of 30.56%. This contributed to the annual value of -$17.8 million for FY2024, which is 82.07% down from last year.
  • Latest data reveals that Exact Sciences reported Other financing activities of -$17.8 million as of FY2024, which was down 82.07% from -$9.8 million recorded in FY2023.
  • Exact Sciences' 5-year Other financing activities high stood at -$1.8 million for FY2020, and its period low was -$17.8 million during FY2024.
  • In the last 3 years, Exact Sciences' Other financing activities had a median value of -$9.8 million in 2023 and averaged -$11.0 million.
  • Data for Exact Sciences' Other financing activities shows a maximum YoY tumbled of 1,326.83% (in 2020) over the last 5 years.
  • Exact Sciences' Other financing activities (Yearly) stood at -$1.8 million in 2020, then plummeted by 201.20% to -$5.3 million in 2021, then fell by 4.62% to -$5.5 million in 2022, then slumped by 76.33% to -$9.8 million in 2023, then slumped by 82.07% to -$17.8 million in 2024.